pharmaphorum

FEBRUARY 1, 2022

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. The post Synthetic control arms in clinical trials: Making it happen appeared first on. But what does it take to implement these innovations?

Clinical Trials 86

Clinical Trials Clinical Trials Trials Engineer 86

pharmaphorum

MAY 30, 2022

Josh Sackman, president and co-founder of AppliedVR, and Web Sun, president and co-founder of Komodo Health, relay how their newly formed collaboration reshapes the clinical trial process by using data, helping to cut costs and allowing for evaluation of broader patient populations. . Distinct offerings.

Clinical Trials 79

Clinical Trials Clinical Trials Trials Big Data 79

pharmaphorum

FEBRUARY 11, 2021

Pharma companies face many challenges when involving patients in the design of clinical trials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. Involving patients in discussions.

Clinical Trials 89

Clinical Trials Clinical Trials Trials Clinical Research 89

XTalks

MAY 11, 2023

Clinical trials are essential for the development of new treatments for rare diseases, but they can be complex and challenging to execute. Patient input is a crucial component of rare disease clinical trials, as it can provide valuable insights into the patient experience and inform decisions about study design and implementation.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Development 97

XTalks

DECEMBER 29, 2022

The life sciences and healthcare are among the biggest industries globally, and their significance was particularly highlighted during the past couple of years by the COVID-19 pandemic. Given the hyperfocus on the life sciences thanks to COVID, consumers appear to be more autonomous and vocal about their medical demands and choices.

Life Science 52

Life Science Gene Therapy Gene Manufacturing 52

Pharmaceutical Technology

OCTOBER 28, 2022

Designed to explain either the risk management plan (RMP) or clinical trial results (CTR) in a way that a child can understand, lay summaries are now a required document for all clinical trials in the European Union (EU) following changes to EU Clinical Trials Regulations (EU-CTR) regulations earlier this year.

Clinical Trials 130

Clinical Trials Clinical Trials Life Science Trials 130

VirTrial

SEPTEMBER 21, 2020

The annual peer-reviewed awards program from the publisher of Fierce Biotech and Fierce Pharma highlights companies that have demonstrated innovative solutions, technologies, and services and have the potential to make the greatest impact for biotech and pharma companies.?. 2020 Accolades. About Fierce Innovation Awards.

Life Science 52

Life Science Clinical Research Coordinator Pharma Companies Clinical Research 52

XTalks

FEBRUARY 17, 2021

And on February 19, join An Insider’s Look: How Syneos Health is Shortening the Distance from Lab to Life in Clinical Trials for key industry HR insights for jobseekers. The company is focused on helping develop and deliver therapeutics to patients by leading clinical trials globally.

Life Science 97

Life Science HR Clinical Research Clinical Trials 97

Drug Discovery World

JULY 2, 2024

DDW’s Diana Spencer takes a closer look into why Switzerland is such a life sciences powerhouse and how Swiss researchers are advancing new technology and tackling modern health challenges. Switzerland, however, boasts three (or arguably, four) separate yet complimentary centres of life science innovation.

Life Science 59

Life Science Drugs Development Research 59

Pharmaceutical Technology

OCTOBER 26, 2022

, revealing a multitude of diverse strategies for pharmaceutical companies to remain conscious of their global impacts. GlobalData is the parent company of Pharmaceutical Technology. These principles also aim to allow an acknowledgement of Black and brown mistrust of clinical trials. Reaching social and governance goals.

Clinical Trials 162

Clinical Trials Clinical Trials Trials Life Science 162

Drug Discovery World

JANUARY 24, 2023

Virtual clinical trials ‘Virtual’ and ‘technology’ are concepts which are readily exchanged in this industry, but these are more than just buzzwords. The overall virtual clinical trials market is currently valued at $7.8 billion, with a projected growth of 14% per annum 1. We’ve shown that this type of model can work.

Clinical Trials 97

Clinical Trials Clinical Trials Drugs Trials 97

XTalks

FEBRUARY 21, 2024

Recently, Eli Lilly revealed promising results from a mid-stage trial, indicating that its popular drug, tirzepatide (marketed as Zepbound and Mounjaro for weight loss and diabetes, respectively), may be an effective treatment for the fatty liver disease metabolic dysfunction-associated steatohepatitis (MASH).

Clinical Trials 59

Clinical Trials Clinical Trials Trials Insulin 59

Drug Discovery World

MAY 6, 2024

Thanks to a prestigious academic legacy, Europe has long been a dominant region for life sciences. Europe is traditionally a life sciences powerhouse, with a strong tradition in pharmaceutical discovery. The oldest, still active pharmaceutical company worldwide, Merck, started life in 1668 in Darmstadt, Germany.

Drugs 59

Drugs Life Science Gene Editing Gene 59

VirTrial

JANUARY 10, 2020

The competition highlights companies that demonstrated innovative solutions, technologies, and services that have the potential to make the greatest impact for biotech and pharma companies. The company was selected for its industry leading Virtual Care Management (VCM) program. To learn more about VirTrial, visit [link].

Clinical Trials 97

Clinical Trials Clinical Trials Clinical Research Pharma Companies 97

pharmaphorum

AUGUST 31, 2021

ECAs are being used to support the primary approval, label expansion of their assets and even go/no-go decisions for trials. For the innovators and early adopters of the life sciences industry, engineering a regulatory-grade ECA can be daunting. Myth 1: There are too many challenges with adopting an ECA.

Clinical Trials 62

Clinical Trials Clinical Trials Life Science Trials 62

XTalks

DECEMBER 20, 2023

As we step into 2024, the life sciences continue to evolve at an unprecedented pace, driven by technological innovation, a deeper understanding of human biology and the application of new technologies in areas like drug development and health wearables. These companies are at various stages of research and clinical trials.

Life Science 119

Life Science Gene Editing Development Clinical Trials 119

pharmaphorum

MARCH 2, 2022

There is a growing pipeline of psychedelic therapies and an expanding body of science to suggest that they may be able to provide an alternative to existing mental health treatments. With promising pre-clinical and clinical stage results, there are more and more therapeutic candidates being developed in this space.

Life Science 94

Life Science Clinical Trials Clinical Trials Trials 94

XTalks

JANUARY 15, 2024

From the continuing trend of the rapid adoption of AI tools to the growing use of real-world evidence (RWE) in regulatory decision-making and a focus on enhancing data integrity, find out how clinical trials will evolve in 2024 to shape the future of medical research. percent from 2023 to 2033.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Clinical Research 105

pharmaphorum

APRIL 5, 2022

And investment in pharma followed suit: pharma companies were looked at as stable assets — reliable but unlikely to balloon in value like a tech company might. The risk equation changed for things like decentralised clinical trials, with companies that lacked the capacity for these trials falling behind.

Pharma R&D 52

Pharma R&D Life Science Pharma Companies Clinical Trials 52

pharmaphorum

JULY 7, 2022

Eradicating cancer is an ambitious goal for oncologists and life science companies around the world. As this issue’s contributors discuss, by working together pharma companies and healthcare providers can significantly enhance oncology treatment for patients. Cancer immunotherapy is a staple of modern oncology.

Vaccination 52

Vaccination Vaccine Life Science Trials 52

pharmaphorum

JANUARY 25, 2022

The Toronto-based company already counts many of the world’s largest pharma companies among its customers, using its platform for a range of tasks such as improving reagent and antibody selection to help scientists run more successful experiments, drawing on data from published studies and organisations’ internal databases.

Life Science 52

Life Science Pharma Companies Reagent Scientist 52

pharmaphorum

DECEMBER 15, 2022

In recent years, social media has evolved into an essential part of pharma operations, for better or worse. Within the life sciences space, traditional ways of leveraging social media include marketing and spreading awareness of a disease or treatment. Clinical trial recruitment. About the author.

Clinical Trials 82

Clinical Trials Clinical Trials Life Science Marketing 82

Pharmaceutical Technology

MAY 24, 2023

By Luisa Sterkel & Joana Loureiro , Tenthpin Consultants The promise and potential of cell and gene therapies (CGT) has emerged in the recent past and currently over 1.500 CGT are registered for clinical trials holding great hope for the treatment of challenging and uncurable diseases.

Clinical Trials 246

Clinical Trials Clinical Trials Gene Therapy Clinical Supply Chain 246

The Pharma Data

SEPTEMBER 11, 2020

In an effort to slow the spread of the disease and prevent a second wave, pharma companies around the world are continuously looking to advance new methods of treatment. This week’s round up dives into developments from companies based in Australia and the US. Saama Technologies, Inc. ,

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drug Delivery 52

The Pharma Data

SEPTEMBER 14, 2020

Supply chain uncertainty is a challenge every clinical supply chain manager wrestles with – stemming from increasing product demand and quality, the growing complexity of clinical trial designs and a lack of visibility in the supply chain. Accelerating your clinical trial supply through digitalization.

Clinical Supply Chain 52

Clinical Supply Chain Clinical Supply Clinical Trials Clinical Trials 52

XTalks

DECEMBER 27, 2022

Boorjian, MD, Carl Rosen Professor and Chair of the Department of Urology at Mayo Clinic, and lead investigator on the recent clinical trial of Adstiladrin, in the company’s press release. The pharma company will expand its manufacturing capacity for commercial scale vector production for oncology treatment.

Gene Therapy 52

Gene Therapy FDA Approval Gene Clinical Trials 52

Drug Discovery World

FEBRUARY 10, 2023

Though not without its challenges, the life sciences industry in Scandinavia is well represented and acts as a serious contender for R&D output. More so, the Karolinska Institute is ranked at number seven in the world for the subjects of life sciences and medicine.

Life Science 52

Life Science Drugs Gene Therapy Manufacturing 52

pharmaphorum

NOVEMBER 23, 2021

The DISC is the biggest investment AZ has ever made, and has been hailed by the pharma company’s chief executive Pascal Soriot as the centrepiece of what he believes could one day become a biotech hub to rival Boston and San Francisco in the US.

Gene Editing 105

Gene Editing Life Science Pharma Companies Clinical Trials 105

XTalks

MAY 3, 2024

According to Real Chemistry, there are currently 119 active GLP-1 agonist clinical trials, with 53 in Phases III or IV, across more than 60 potential new indications for GLP-1 treatment.

Drugs 52

Drugs Clinical Trials Clinical Trials Marketing 52

pharmaphorum

OCTOBER 11, 2022

“Because digital permeates every aspect of the industry, and people are often talking about digital and maybe talking about very different things, I think about the journey of healthcare and life science companies in three stages,” he explained. The first stage of digital transformation was really all about communications.

Pharma Companies 82

Pharma Companies Medicine Doctors Doctor 82

XTalks

MAY 31, 2024

Efficacy and Safety of Exblifep The FDA approved Exblifep based on clinical evidence that included the Phase III ALLIUM trial. This trial was conducted at 90 sites across Europe, North and Central America, South America and South Africa, and 1,041 adult patients participated. In trial, oral sulopenem had a success rate of 61.7

Bacteria 52

Bacteria FDA Approval Trials Pharma Companies 52

pharmaphorum

FEBRUARY 17, 2021

Armed with these insights, life sciences companies can develop patient-centric solutions that will lead to more successful products. Taking an engaged approach has clear benefits, including improved trial retention and development of PROs that can support market-entry and market access. Read the full article here.

Life Science 90

Life Science Branding Genetics Trials 90

Drug Discovery World

JULY 18, 2022

Troy Groetken of intellectual property and technology law firm McAndrews, Held & Malloy tells Lu Rahman how pharma companies can take this data from where it currently stands (drug design and development) to a more clinical level. Groetken sees many opportunities to utilise big data and AI in pharma. The patient?

Big Data 52

Big Data Life Science Development Clinical Trials 52

XTalks

AUGUST 21, 2023

Early detection can significantly help improve the longevity and quality of life of FOP patients. Safety and Effectiveness of Sohonos The Phase III MOVE trial evaluated the safety and efficacy of palovarotene in decreasing new HO in participants with FOP. The Phase III trial consisted of three parts, with 107 participants enrolled.

Drugs 98

Drugs FDA Approval Genetics Clinical Trials 98

Drug Discovery World

DECEMBER 14, 2023

The new hub will become a part of the already thriving life sciences sector in the Glasgow area, most of which is centred around the university, the Cancer Research UK Scotland Institute and the BioCity cluster, making Glasgow and its surrounds one of the most important regions for drug discovery and development in the UK.

Drugs 75

Drugs Life Science Research Scientist 75

pharmaphorum

SEPTEMBER 7, 2022

Pharma has a great opportunity ahead of it when it comes to conducting representative clinical trials. The processes used are now seeing huge infrastructure commitments, in order to cement their place in the development of future products and trials. But our drug development processes are not perfect.

Clinical Trials 87

Clinical Trials Clinical Trials Trials Genetics 87

pharmaphorum

JANUARY 26, 2021

From telehealth to digital trials, customer engagement to healthcare data, Healthware Group outlines the key trends that are expected to shake up digital health this year. There are several important aspects to these shifts for pharma, biotech and medical device companies, so what can we expect to see over the next 12 months and beyond?

Clinical Trials 134

Clinical Trials Clinical Trials Sales Life Science 134